Trials / Completed
CompletedNCT00109486
Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray
A Randomised, Double-Blind, Placebo-Controlled, Two-Week Crossover, Knemometric Assessment of the Effect of Fluticasone Furoate Nasal Spray 100mcg Once Daily on Short-Term Growth in Children Aged 6 to 11 Years With Seasonal and/or Perennial Allergic Rhinitis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 6 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess any effect in children with seasonal and/or perennial allergic rhinitis by GW685698X aqueous nasal spray (versus vehicle placebo nasal spray) on growth using knemometry.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GW685698X |
Timeline
- Start date
- 2005-04-01
- Primary completion
- 2005-11-01
- Completion
- 2005-11-01
- First posted
- 2005-04-29
- Last updated
- 2016-09-15
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00109486. Inclusion in this directory is not an endorsement.